ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
Stock Information for ARCA biopharma Inc.
Loading
Please wait while we load your information from QuoteMedia.